accountwell as its first ever press conference as well as the impact on the market. In deal news, Johnson & Johnson shed 0.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
JOHNSON & JOHNSON
Johnson & Johnson is a global pharmaceutical, medical devices and consumer packaged goods manufacturer. Founded in 1886, J&J now includes about 250 subsidiaries in more than 57 countries. A household name in the U.S., the company’s products are sold in more than 175 countries. The topic covers Johnson & Johnson the company, its products and market updates.
Johnson & Johnson is part of Business Exchange, suggested by
Carlton St Bernard.
This topic contains
1,302 news
and
1,890 blog
items.
Read updated news, blogs, and resources about Johnson & Johnson. Find user-submitted articles and reactions on Johnson & Johnson from
like-minded professionals.
News
Please add new articles to this topic
April 27 (Bloomberg) -- Johnson & Johnson agreed to buy Synthes Inc. for $21.3 billion in the biggest purchase of...
well as its first ever press conference as well as the impact on the market. In deal news, Johnson & Johnson shed 0.
Extract not available.
aggressive hedge-fund traders who move in once a company is in play, will be satisfied with the price J&J is...
Johnson & Johnson said Wednesday that it had agreed to buy Synthes, the medical equipment maker, for $21.
Extract not available.
Johnson & Johnson said Wednesday that it had agreed to buy Synthes, the medical equipment maker, for $21.
Extract not available.
(Updates to add terms in fifth paragraph.) April 27 (Bloomberg) -- Johnson & Johnson agreed to buy Synthes Inc.
���s bid for Synthes, a Swiss-American medical equipment manufacturer, makes a lot of strategic sense. The $21.
SYDNEY (MarketWatch) -- Johnson & Johnson (NYSE:JNJ
Extract not available.
quotes in this article:JNJ NEW BRUNSWICK, N.J. and WEST CHESTER, Pa., April 27, 2011 /PRNewswire/ -- Johnson &...
Johnson & Johnson, which has grown into a health-care powerhouse by acquiring small firms, is no stranger to making...
Johnson & Johnson will acquire medical-device maker Synthes for $21.3 billion, giving the U.S. health-products...
is factoring into today's trading, as well as whether stocks can continue their climb, Boeing earnings and J&J's...
well as its first ever press conference as well as the impact on the market. In deal news, Johnson & Johnson shed 0.
Extract not available.
Extract not available.
15. Synthes shares closed down 1.4% at 146.50 francs in trading Tuesday on the Swiss exchange. J&J is expected to...
of 38 cents a share, earlier this month agreed to split sales for the arthritis drug Remicade with Johnson &...
agreed to buy the company for $2.5 billion to add so-called cloud- computing services for business customers.
Extract not available.
tempered by a warning from S&P that Japan's debt could be at risk for a downgrade. Companies: Johnson & Johnson...
Top Sources: Johnson & Johnson
- Financial Times
- BusinessWeek
- Reuters
- Motley Fool
- TheStreet.com
- thedeal.com
- New York Times
- Wall Street Journal Online
- MarketWatch
- youtube.com
Post a Job
Jobs in this Topic
Rep, Phlebotomy Services (part-time) and in client office position located in Johnson Ferry are
Questdiagnostics
|
Atlanta, GA
Posted: Apr 3